Company Filing History:
Years Active: 2024-2025
Title: Andreas Jeromin: Innovator in Alzheimer's Disease Research
Introduction
Andreas Jeromin is a notable inventor based in Alachua, FL (US), recognized for his contributions to the field of Alzheimer's disease research. With a total of 5 patents, he has made significant strides in developing innovative assays and methods that enhance the understanding and diagnosis of this debilitating condition.
Latest Patents
Jeromin's latest patents include groundbreaking work on phospho-tau antibodies and methods of use. These patents provide compositions and methods that relate to improved assays for establishing Alzheimer's disease. Additionally, he has developed methods for quantifying neurofilament light chain in physiological samples. This work focuses on immunoassays for NF-L performed on liquid samples derived from physiological fluids, such as venous blood, to detect the presence or absence of a physiological condition.
Career Highlights
Throughout his career, Jeromin has worked with prominent companies in the field, including Quanterix Corporation and Alzpath, Inc. His expertise and innovative approach have positioned him as a key figure in the development of diagnostic tools for Alzheimer's disease.
Collaborations
Jeromin has collaborated with notable professionals in the industry, including Edward Kevin Hrusovsky and David Wilson. These partnerships have furthered his research and contributed to advancements in the field.
Conclusion
Andreas Jeromin's work in Alzheimer's disease research exemplifies the impact of innovation in medical diagnostics. His patents and collaborations highlight his commitment to improving the understanding and treatment of this complex condition.